Lantheus to Present at the William Blair 46th Annual Growth Stock Conference
Lantheus (NASDAQ: LNTH) announced that John Wiggins, Vice President, External Manufacturing, will join a fireside chat at the William Blair 46th Annual Growth Stock Conference at 12:10 p.m. ET on Wednesday, June 3.
Rhea-AI Summary
Lantheus (NASDAQ: LNTH) announced that John Wiggins, Vice President, External Manufacturing, will join a fireside chat at the William Blair 46th Annual Growth Stock Conference at 12:10 p.m. ET on Wednesday, June 3. A live webcast and 30-day replay will be available via the company’s investor website.
Positive
- None.
Negative
- None.
Details
News Market Reaction – LNTH
In the May 27 session, LNTH declined 0.97%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Q1 2026 revenue
- $377.3M
- Reported in first quarter 2026 financial results
- Q1 2026 GAAP net income
- $118.4M
- Reported in first quarter 2026 results
- Q1 2026 GAAP EPS
- $1.80
- Fully diluted EPS versus $1.02 a year earlier
- Q1 2026 adjusted EPS
- $1.46
- Adjusted earnings per share for Q1 2026
- Cash and equivalents
- $498.6M
- Balance as of Q1 2026, including $31.4M from SPECT divestiture
- 2026 revenue guidance
- $1.4B–$1.45B
- Reaffirmed full-year 2026 revenue outlook
- 2026 adjusted EPS guidance
- $5.00–$5.25
- Reaffirmed full-year 2026 adjusted EPS outlook
- Market capitalization
- $6,514,514,565
- Pre-news market value based on latest provided data
Historical Context
-
Announced new PSMA-PET and 18F-GP1 radiodiagnostic data presentations.
-
Detailed new radiopharmaceutical data to be presented at ASCO 2026.
-
Reported strong Q1 results, FDA approval of PYLARIFY TruVu, reaffirmed guidance.
-
Announced schedule and access details for Q1 2026 earnings call.
-
Disclosed three-month FDA PDUFA extension for LNTH-2501 to June 29, 2026.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BEDFORD, Mass., May 27, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company dedicated to helping clinicians Find, Fight, and Follow disease to deliver better patient outcomes, today announced John Wiggins, Vice President, External Manufacturing, will participate in a fireside chat at the William Blair 46th Annual Growth Stock Conference at 12:10 p.m. ET on Wednesday, June 3.
To access the live webcast of the presentations, please visit the Investors section of the Company’s website at www.lantheus.com. A replay of the webcasts will be available on the Company’s website for at least 30 days following the live presentation.
About Lantheus
Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in New Jersey, Canada, Germany, Sweden, Switzerland, and the United Kingdom, Lantheus has been providing radiopharmaceutical solutions for 70 years. For more information, visit www.lantheus.com.
Contacts:
Mark Kinarney
Vice President, Investor Relations
978-671-8842
ir@lantheus.com
Melissa Downs
Executive Director, External Communications
646-975-2533
media@lantheus.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.